Cash & equivalents decreased 30.3%
Cash & equivalents changed -30.3% from the comparable as-filed period. The change ranks at the 49th percentile of 236 prior comparable changes.
$816.0M→$569.0M236 prior comparisons
GROSSPATTERN / DETERMINISTIC EVIDENCE / V3
Search securities →IFF financial changes
Ranked by interpretable importance, issuer history, magnitude, and accounting profile. No directional recommendation.
Debt increased 92.8%
Debt changed +92.8% from the comparable as-filed period. The change ranks at the 81th percentile of 112 prior comparable changes.
$500.0M→$964.0M112 prior comparisons
Gross margin moved 639 bp higher
Gross margin changed +639 basis points from the comparable as-filed period. The change ranks at the 89th percentile of 65 prior comparable changes.
37.26%→43.65%65 prior comparisons
Gross profit decreased 17.2%
Gross profit changed -17.2% from the comparable as-filed period. The change ranks at the 75th percentile of 95 prior comparable changes.
$1.0B→$853.0M95 prior comparisons
Inventory decreased 36.5%
Inventory changed -36.5% from the comparable as-filed period. The change ranks at the 87th percentile of 120 prior comparable changes.
$2.4B→$1.5B120 prior comparisons
Net income decreased 91.8%
Net income changed -91.8% from the comparable as-filed period. The change ranks at the 76th percentile of 135 prior comparable changes.
$612.0M→$50.0M135 prior comparisons
Operating income decreased 20.2%
Operating income changed -20.2% from the comparable as-filed period. The change ranks at the 64th percentile of 126 prior comparable changes.
$198.0M→$158.0M126 prior comparisons
Revenue decreased 29.3%
Revenue changed -29.3% from the comparable as-filed period. The change ranks at the 74th percentile of 65 prior comparable changes.
$2.8B→$2.0B65 prior comparisons
Operating margin moved 92 bp higher
Operating margin changed +92 basis points from the comparable as-filed period. The change ranks at the 5th percentile of 65 prior comparable changes.
7.16%→8.09%65 prior comparisons
Research & development decreased 6.6%
Research & development changed -6.6% from the comparable as-filed period. The change ranks at the 61th percentile of 135 prior comparable changes.
$182.0M→$170.0M135 prior comparisons
Selling, general & administrative decreased 9.5%
Selling, general & administrative changed -9.5% from the comparable as-filed period. The change ranks at the 58th percentile of 135 prior comparable changes.
$483.0M→$437.0M135 prior comparisons
Stock-based compensation unchangedd 0.0%
Stock-based compensation changed +0.0% from the comparable as-filed period. The change ranks at the 0th percentile of 131 prior comparable changes.
$33.0M→$33.0M131 prior comparisons
Method Importance combines metric-family relevance, magnitude, issuer-history unusualness, persistence, and financial-statement significance. It is analytical prioritization, not a legal materiality conclusion or investment signal.